Muscle weakness has a limited effect on motor control of gait in Duchenne muscular dystrophy

Ines Vandekerckhove1,2, Nathalie De Beukelaer1,2, Marleen Van den Hauwe1,3

  • 1Department of Rehabilitation Sciences, KU Leuven, Leuven, Belgium.

Plos One
|September 3, 2020
PubMed

Insights

Muscle synergy weights and activations in children with Duchenne muscular dystrophy (DMD) were similar to typical developing children, despite DMD-related weakness. Non-neural factors may limit the influence on muscle synergies.

Area of Science:

  • Biomechanics
  • Neuromuscular Physiology
  • Movement Science

Background:

  • Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive muscle weakness.
  • Muscle synergies, the coordinated activation patterns of muscles, are crucial for efficient movement.
  • Understanding alterations in muscle synergies in DMD can provide insights into motor control deficits.

Purpose of the Study:

  • To investigate if muscle synergy weights and activations differ in children with DMD compared to typically developing (TD) children.
  • To determine if any observed alterations in muscle synergies are associated with muscle weakness in DMD.

Main Methods:

  • Surface electromyography (sEMG) was recorded during gait in 22 children with DMD and 22 TD children.
  • Muscle weakness was assessed using maximal voluntary isometric contractions (MVIC).
  • Non-negative matrix factorization (NMF) was used to calculate muscle synergies, with differences analyzed using Mann-Whitney U and Hotelling's T2 tests.

Main Results:

  • The average number of synergies explaining 90% of the variance (N90) was similar (three) in both groups.
  • DMD participants showed altered weights in specific synergies (increased rectus femoris, decreased medial gastrocnemius).
  • Synergy activations were largely similar between groups, with minor differences in combined activations during mid-swing; weakness was not correlated with these changes.

Conclusions:

  • Muscle synergy weights and activations are largely preserved in children with DMD, despite significant muscle weakness.
  • The findings suggest that non-neural factors may play a limited role in modifying muscle synergies in DMD.
  • Further research is needed to elucidate the precise mechanisms underlying motor control in DMD.
Abstract

Related Concept Videos

Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.5K
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.2K
Cross-bridge Cycle01:26

Cross-bridge Cycle

As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
121.4K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.5K
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
10.9K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.7K